294 related items for PubMed ID: 15996060
1. Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy.
Straub RH, Härle P, Atzeni F, Weidler C, Cutolo M, Sarzi-Puttini P.
J Rheumatol; 2005 Jul; 32(7):1253-8. PubMed ID: 15996060
[Abstract] [Full Text] [Related]
2. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
Straub RH, Härle P, Yamana S, Matsuda T, Takasugi K, Kishimoto T, Nishimoto N.
Arthritis Rheum; 2006 Jun; 54(6):1778-85. PubMed ID: 16729287
[Abstract] [Full Text] [Related]
3. Anti-TNF and sex hormones.
Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Pizzorni C, Paolino S, Seriolo B, Felli L, Straub RH.
Ann N Y Acad Sci; 2006 Jun; 1069():391-400. PubMed ID: 16855166
[Abstract] [Full Text] [Related]
4. Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function.
Ernestam S, Hafström I, Werner S, Carlström K, Tengstrand B.
J Rheumatol; 2007 Jul; 34(7):1451-8. PubMed ID: 17477470
[Abstract] [Full Text] [Related]
5. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis.
Straub RH, Paimela L, Peltomaa R, Schölmerich J, Leirisalo-Repo M.
Arthritis Rheum; 2002 Mar; 46(3):654-62. PubMed ID: 11920401
[Abstract] [Full Text] [Related]
6. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
Straub RH, Pongratz G, Schölmerich J, Kees F, Schaible TF, Antoni C, Kalden JR, Lorenz HM.
Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
[Abstract] [Full Text] [Related]
7. Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol.
Straub RH, Sarzi-Puttini P, Atzeni F, Buttgereit F, Carrabba M, Cutolo M.
Ann Rheum Dis; 2005 Sep; 64(9):1353-6. PubMed ID: 15708882
[Abstract] [Full Text] [Related]
8. Sex steroid hormones in primary Sjögren's syndrome.
Brennan MT, Sankar V, Leakan RA, Grisius MM, Collins MT, Fox PC, Baum BJ, Pillemer SR.
J Rheumatol; 2003 Jun; 30(6):1267-71. PubMed ID: 12784401
[Abstract] [Full Text] [Related]
9. Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.
Sarzi-Puttini P, Atzeni F, Schölmerich J, Cutolo M, Straub RH.
Ann Rheum Dis; 2006 Mar; 65(3):301-5. PubMed ID: 16079165
[Abstract] [Full Text] [Related]
10. Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.
Popa C, Netea MG, de Graaf J, van den Hoogen FH, Radstake TR, Toenhake-Dijkstra H, van Riel PL, van der Meer JW, Stalenhoef AF, Barrera P.
J Rheumatol; 2009 Apr; 36(4):724-30. PubMed ID: 19273452
[Abstract] [Full Text] [Related]
11. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
Vogl D, Falk W, Dorner M, Schölmerich J, Straub RH.
J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
[Abstract] [Full Text] [Related]
12. Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis.
Straub RH, Pongratz G, Cutolo M, Wijbrandts CA, Baeten D, Fleck M, Atzeni F, Grunke M, Kalden JR, Schölmerich J, Lorenz HM, Tak PP, Sarzi-Puttini P.
Arthritis Rheum; 2008 Apr; 58(4):976-84. PubMed ID: 18383357
[Abstract] [Full Text] [Related]
13. Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: a prerequisite for local androgen deficiency.
Weidler C, Struharova S, Schmidt M, Ugele B, Schölmerich J, Straub RH.
Arthritis Rheum; 2005 Jun; 52(6):1721-9. PubMed ID: 15934093
[Abstract] [Full Text] [Related]
14. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis.
Popa C, Netea MG, Radstake TR, van Riel PL, Barrera P, van der Meer JW.
Ann Rheum Dis; 2005 Aug; 64(8):1195-8. PubMed ID: 15731289
[Abstract] [Full Text] [Related]
15. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, Fischkoff SA, Chartash EK.
J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
[Abstract] [Full Text] [Related]
16. Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation.
Tengstrand B, Carlström K, Felländer-Tsai L, Hafström I.
J Rheumatol; 2003 Nov; 30(11):2338-43. PubMed ID: 14677174
[Abstract] [Full Text] [Related]
17. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
Montecucco C, Caporali R, Caprotti P, Caprotti M, Notario A.
J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
[Abstract] [Full Text] [Related]
18. Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases--substitutes of adrenal and sex hormones.
Straub RH, Schölmerich J, Zietz B.
Z Rheumatol; 2000 Dec; 59 Suppl 2():II/108-18. PubMed ID: 11155790
[Abstract] [Full Text] [Related]
19. B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.
Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, Revaz S, Dudler J, Gabay C, Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis.
Arthritis Rheum; 2007 May; 56(5):1417-23. PubMed ID: 17469098
[Abstract] [Full Text] [Related]
20. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids.
Cutolo M, Foppiani L, Prete C, Ballarino P, Sulli A, Villaggio B, Seriolo B, Giusti M, Accardo S.
J Rheumatol; 1999 Feb; 26(2):282-8. PubMed ID: 9972959
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
